A phase II study of perifosine in androgen independent prostate cancer. [electronic resource]
Producer: 20060622Description: 1133-7 p. digitalISSN:- 1538-4047
- Aged
- Aged, 80 and over
- Androgens -- physiology
- Antineoplastic Agents -- administration & dosage
- Disease Progression
- Drug Administration Schedule
- Humans
- Leukapheresis
- Male
- Middle Aged
- Neoplasm Metastasis
- Phosphorylcholine -- administration & dosage
- Prostate-Specific Antigen -- blood
- Prostatic Neoplasms -- blood
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article
There are no comments on this title.
Log in to your account to post a comment.